The pharmacy market - Italy

Since 2020, the global pharmaceutical market has seen a significant increase in valuation, reaching approximately $1.27 trillion by the end of 2020, marking substantial growth from $390 billion in 2001. The Italian pharmacy market experienced a slight contraction during the pandemic by -1.7%, but projections for 2022 anticipated exceeding 2019 sales figures, reaching above $30 billion. The number of pharmacies in Italy expanded, with about 19,100 outlets, despite declining individual pharmacy profitability. The pandemic also significantly boosted online pharmacy purchases, with Italian e-commerce accelerating by 66% in 2020 relative to 2019’s value of approximately 234 million euros. Despite a modest share of the total market, the future of e-commerce appears promising. Italy hosts key global pharmaceutical groups, and the industry's commitment to research has strengthened, exemplified by an investment of €1.6 billion in R&D in 2020, marking a 6% increase from 2019. Italian pharmacies have engaged actively in the fight against COVID-19, with a sizeable number offering vaccination services. The annual number of pharmacy graduates in Italy aligns with a stabilized workforce over the past five years, and the majority of pharmacy graduates find employment across various sectors, with 88,000 individuals currently employed in the industry. The rise of parapharmacies continues, with 4163 units in 2018, a significant increase since 2008. Online commerce in the pharmaceutical sector has seen double-digit growth, with sales expected to reach €315 million in 2020, while the Italian market for COVID-19-related products soared, with sales of tests alone totaling €176.9 million in the initial weeks of 2022. Lastly, the cosmetics segment within pharmacies underwent a 3.5% decline in 2020, but still managed a turnover of 1.8 billion euros, indicating an evolving landscape of demand influenced by the pandemic..Title: Italian Pharmacy Market Dynamics and Consumer Behavior Post-Covid Following the impact of the Covid-19 pandemic, the Italian pharmacy market witnessed a series of significant transformations influenced by changes in consumer behavior, regulations, and economic conditions. The country, which is known for hosting some of the prominent global pharmaceutical groups like Menarini and Chiesi, saw a slight contraction in the pharmacy market during the pandemic, with a decline of approximately 1.7%. However, expectations for the market rebounded with projections for sales to exceed $30 billion, potentially outpacing the sales figures recorded in 2019. Despite the presence of around 19,100 pharmacies distributed across Italy, there has been a noticeable decline in the average profitability, attributed partly to the increasing number of new pharmacies opening each year— about 300. This surge has led to a narrower individual pharmacy's catchment area by roughly 7% over a period of three years. The pandemic also reshaped the digital landscape for pharmacies, considerably boosting online pharmacy sales. In Italy, the pharmacy e-commerce sector surged by 66% in 2020 compared to its 2019 figures when it was valued at approximately between 200 and 250 million euros. While the online segment accounts for a slender slice of the total market, its positive trajectory suggests a promising future. Consumer trends in Italy highlight an increased consumption of pharmaceutical products, with Italy demonstrating one of the few consistent upward consumption trends amongst European countries. Prescription drugs, especially those classified under Bands A and C, retain the lion's share in pharmacy turnover, reaching close to 14 billion euros in 2020. The demand for self-medication products also reflected a significant proportion of the turnover, amounting to approximately 9%. Parallel to the domestic market, trade flows in pharmaceutical products presented a wholesome picture. Italy's pharmaceutical product imports and exports registered in the millions, with the United States emerging as the leading export destination for Italian pharmaceuticals, holding almost 40% of the total exports. Notably, the Italian pharmaceutical industry has increasingly invested in research, particularly highlighted by the Covid-19 pandemic. In 2020 alone, pharmaceutical companies injected €1.6 billion into R&D activities. This commitment to innovation and development positions Italy as a formidable player in the European pharmaceutical landscape, reflecting in the substantial number of biomedical research publications and patents filed by Italian companies. On the distribution front, pharmacies remain the predominant channel for pharmaceutical sales, both for prescription and over-the-counter (OTC) drugs, boasting a turnover of approximately .### Leading Forces in the Italian Pharmaceutical Landscape The Italian pharmaceutical market is shaped by a number of prominent companies that have established a strong presence both domestically and internationally. These companies are not only fundamental players in the Italian market but also contribute significantly to the global pharmaceutical industry through their research, production, and innovation efforts. Below are the key actors that have been instrumental in driving progress in the pharmaceutical sector in Italy. #### Menarini Group Established in 1886 in Florence, the Menarini Group has grown to become the leading Italian pharmaceutical company in the world, with a presence across over 140 countries. Renowned for its commitment to research and development, Menarini is dedicated to producing a wide range of pharmaceutical products, focusing on various therapeutic areas and investing substantially in the advancement of medical science. #### Chiesi Farmaceutici Chiesi Farmaceutici, headquartered in Parma, has made its mark as a global leader in the pharmaceutical industry. With a deep-rooted heritage dating back to 1935, Chiesi is a research-focused company that specializes in developing innovative respiratory, neonatology, rare disease, and special care medicine solutions that cater to the needs of healthcare providers and patients alike. #### Bracco Imaging As a subsidiary of the Bracco Group, Bracco Imaging specializes in the diagnostic imaging sector. The company has established itself as a pioneer in the production of contrast agents and advanced imaging modalities. Bracco's commitment to excellence in imaging diagnostics aids physicians in offering accurate and early diagnoses, enhancing patient outcomes. #### Recordati Recordati, founded in 1926, is an international pharmaceutical group with a strong dedication to the research, development, manufacturing, and marketing of pharmaceuticals. They have a robust portfolio of original and generic medications that address a multitude of health conditions, aiming to improve the quality of life for patients globally. #### Alfasigma Alfasigma stands as a major pharmaceutical company focusing on research, development, and the commercialization of prescription drugs. The company is particularly committed to gastrointestinal and vascular diseases, providing innovative healthcare solutions and therapeutic approaches to these common ailments. #### Angelini Pharma Angelini Pharma is a key player with a strong international footprint, particularly known for its extensive work in the fields of mental health, gynecology, and consumer health. Angelini Pharma is dedicated to improving patients' lives through the continuous pursuit of innovation and the development of effective therapeutic solutions. #### Italfarmaco With operations spanning the globe, Italfarmaco is a dynamic and prominent

Informazioni

• Pagine : 30 pags
• Formato : Versione PDF e digitale
• Ultimo aggiornamento : 15/06/2022

Riepilogo ed estratti

Grafica

• Spesa del mercato globale dell'industria farmaceutica
• Il mercato farmaceutico globale per area geografica
• Quota del mercato dei farmaci ed extrafarmaci per segmento
• Evoluzione del valore e volume del mercato dei farmaci e extrafarmaci
• Fatturato generato dalle farmacie
• Variazione del consumo pro capite di farmaci
• Fatturato delle farmacie per categorie di prodotto
• Esportazioni di prodotti farmaceutici
• Importazioni di prodotti farmaceutici
• Valore degli scambi commerciali di prodotti farmaceutici
• Prime 10 aziende farmaceutiche mondiali
• Evoluzione del fatturato dei distributori di farmaci ed extrafarmaci per canale distributivo
• Distribuzione del volume di vendita totale delle farmacie per categorie
• Numero di farmacie in proporzione alla popolazione
• I laureati in farmacia
• I vari ambiti di occupazione dei laureati in farmacia
• Distribuzione geografica delle parafarmacie
• Evoluzione del numero di parafarmacie e corner della GDO
• Numero di farmacie e parafarmacie autorizzate a vendere online
• Variazione dei prezzi dei medicinali
• Prezzo medio dei farmaci e dei prodotti farmaceutici venduti in farmacia
• Vendite semestriali di prodotti contro il Covid-19
• Composizione percentuale delle vendite di cosmetici in parafarmacia per tipologia di prodotto
• Fatturato dei cosmetici venduti nelle farmacie